Compare BWEN & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BWEN | BRNS |
|---|---|---|
| Founded | N/A | 2016 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.1M | 55.9M |
| IPO Year | N/A | 2021 |
| Metric | BWEN | BRNS |
|---|---|---|
| Price | $3.58 | $0.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $6.00 | $4.00 |
| AVG Volume (30 Days) | ★ 263.3K | 65.0K |
| Earning Date | 03-04-2026 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 63.89 | N/A |
| EPS | ★ 0.23 | N/A |
| Revenue | ★ $153,877,000.00 | N/A |
| Revenue This Year | $11.68 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $15.55 | ★ N/A |
| Revenue Growth | N/A | ★ 1766.46 |
| 52 Week Low | $1.41 | $0.64 |
| 52 Week High | $4.15 | $2.92 |
| Indicator | BWEN | BRNS |
|---|---|---|
| Relative Strength Index (RSI) | 56.30 | 45.83 |
| Support Level | $3.32 | $0.71 |
| Resistance Level | $4.15 | $0.74 |
| Average True Range (ATR) | 0.29 | 0.04 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 56.99 | 60.88 |
Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through four operating segments namely Heavy Fabrications, Gearing, Industrial Solutions and Corporate.
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.